Stockholm - Delayed Quote SEK
ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
At close: November 7 at 5:22 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-38,955.00
-100,887.00
-99,614.00
-45,646.00
-18,175.00
Investing Cash Flow
21,154.00
-2,015.00
105,325.00
-100,921.00
-1,079.00
Financing Cash Flow
271.00
47,836.00
61,460.00
74,545.00
123,382.00
End Cash Position
70,772.00
57,597.00
110,974.00
37,111.00
106,832.00
Capital Expenditure
-911.00
-2,015.00
-383.00
-715.00
-885.00
Issuance of Capital Stock
3,383.00
60,719.00
75,960.00
83,304.00
143,183.00
Issuance of Debt
--
--
--
--
3,172.00
Repayment of Debt
--
--
--
-1,361.00
--
Free Cash Flow
-39,866.00
-102,902.00
-99,997.00
-46,361.00
-19,060.00
12/31/2020 - 7/29/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SANION.ST Saniona AB (publ)
3.0000
-6.10%
BAVA.CO Bavarian Nordic A/S
204.00
+2.00%
FLUO.ST FluoGuide A/S
38.40
+7.87%
GUBRA.CO Gubra A/S
425.00
-1.39%
SCOL.ST Scandion Oncology A/S
0.0800
-10.61%
HNSA.ST Hansa Biopharma AB (publ)
33.34
+3.16%
ACE.ST Ascelia Pharma AB (publ)
2.3550
+12.95%
COMBI.ST CombiGene AB (publ)
2.6600
0.00%
ZEAL.CO Zealand Pharma A/S
813.50
-5.08%
GMAB.CO Genmab A/S
1,589.50
+4.33%